SEC Form 4 · accession 0001209191-16-102790
VERTEX PHARMACEUTICALS INC / MA · VRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joshua S Boger
Director
Period of report
Feb 24, 2016
Accepted (ET)
Feb 26, 2016 · 3:39 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875320
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 24, 2016 | M | 5,130 | $35.35 | A | 274,425 | D | |
| Common StockF2,F3 | Feb 24, 2016 | S | 200 | $82.90 | D | 274,225 | D | |
| Common StockF2,F4 | Feb 24, 2016 | S | 1,400 | $84.03 | D | 272,825 | D | |
| Common StockF2,F5 | Feb 24, 2016 | S | 1,700 | $85.20 | D | 271,125 | D | |
| Common StockF2,F6,F7 | Feb 24, 2016 | S | 1,830 | $86.50 | D | 269,295 | D | |
| Common Stock | holding | — | — | — | 13,286 | I | 401k | |
| Common StockF7 | holding | — | — | — | 118,689 | I | Common Stock Held In Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F8 | $35.35 | Feb 24, 2016 | M | 5,130 | D | — | Jul 19, 2016 | Common Stock | 5,130 | 97,480 | D |
Explanation of responses
- F1Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.
- F2Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- F3Open market sales reported on this line occurred at a weighted average price of $82.90 (range $82.62 to $83.18).
- F4Open market sales reported on this line occurred at a weighted average price of $84.03 (range $83.80 to $84.72).
- F5Open market sales reported on this line occurred at a weighted average price of $85.20 (range $84.85 to $85.67).
- F6Open market sales reported on this line occurred at a weighted average price of $86.50 (range $85.88 to $86.78).
- F7Reflects a change in the form of ownership resulting from a 02/24/2016 distribution of 4,011 shares from a trust to Dr. Boger.
- F8Fully vested.